Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Nicholas Ferrentino is active.

Publication


Featured researches published by Nicholas Ferrentino.


The American Journal of Gastroenterology | 1999

Severe hepatotoxicity associated with bromfenac sodium

Peter L. Moses; Brad Schroeder; Ousama Alkhatib; Nicholas Ferrentino; Thomas Suppan; Steven D. Lidofsky

ABSTRACTSubacute hepatitis and liver failure occurred in a 40-yr-old woman following a 1-month course of treatment with the nonsteroidal anti-inflammatory drug bromfenac. Serologies for hepatitis A, B, and C were negative, as were antinuclear antibodies and ceruloplasmin. A transjugular liver biopsy demonstrated submassive hepatic necrosis. The clinical course was complicated by encephalopathy, fluid retention, and spontaneous bacterial peritonitis, prompting consideration for liver transplantation. With supportive measures, jaundice and fluid retention resolved over a 3-month period. We conclude that prolonged use of bromfenac was the etiological agent in this case, and that this drug can cause severe hepatotoxicity resulting in liver failure.


The American Journal of Gastroenterology | 2003

Health-related quality of life (HRQOL) subsequent to esophageal adenocarcinoma staging with endoscopic ultrasound (EUS)

Richard Zubarik; Donna Benway; Peter L. Moses; Nicholas Ferrentino

Health-related quality of life (HRQOL) subsequent to esophageal adenocarcinoma staging with endoscopic ultrasound (EUS)


Journal of Hepatology | 2005

Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis C

Edward L. Krawitt; Takamaru Ashikaga; Stuart R. Gordon; Nicholas Ferrentino; Mary Ann Ray; Steven D. Lidofsky


The American Journal of Gastroenterology | 2002

Procedure-related abdominal discomfort in patients undergoing colorectal cancer screening: a comparison of colonoscopy and flexible sigmoidoscopy.

Richard Zubarik; Eric K. Ganguly; D Benway; Nicholas Ferrentino; Peter L. Moses; James A. Vecchio


Postgraduate Medicine | 1998

Inflammatory bowel disease. 1. Origins, presentation, and course.

Peter L. Moses; Brad R. Moore; Nicholas Ferrentino; Steven P. Bensen; James A. Vecchio


Gastroenterology | 2002

Angiotensin receptor antagonists in portal hypertension: Fog over paradise

Christian A. Speer; Nicholas Ferrentino


Gastroenterology | 2003

Serotonin signaling in the mucosa of the human colon

Matthew Coates; Peter L. Moses; Christine R. Mahoney; David R. Linden; James A. Vecchio; Nicholas Ferrentino; Richard Zubarik; Michael D. Crowell; Keith A. Sharkey; Gary M. Mawe


Gastroenterology | 1998

Suppression of duodenal motility during ERCP by L-hyoscyamine versus glucagon: A randomized, prospective, double blinded trial*

Peter L. Moses; O. Alkhatib; R. Mitty; Nicholas Ferrentino; R. Rothstein; P.W. Callas; James A. Vecchio


Postgraduate Medicine | 1998

Inflammatory bowel disease. 2. Current and future therapeutic options.

Peter L. Moses; Moore Br; Nicholas Ferrentino; Steven P. Bensen; James A. Vecchio


Hepatology | 2003

1202 Comparison of low dose with standard dose PEG-interferon alfa-2B plus rivavirin for initial treatment of chronic hepatitis C

C. Edward L. Krawitt; Norman D. Grace; Stuart R. Gordon; Hans Fromm; Melissa Palmer; Joseph C. Yarze; Alan Sheinbaum; Robert D. Thomson; Sam Moskowitz; Liviu Schapira; James G. Corsanti; John Polio; Robert E. Smith; Robert A. Levine; Leslie Bank; Alan E. Kilby; Martin B. Fried; Louis V. Antignano; Kenneth R. Kohagen; Nicholas Ferrentino; Steven D. Lidofsky; Douglas R. LaBrecque

Collaboration


Dive into the Nicholas Ferrentino's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D Benway

University of Vermont

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge